Continued controversies in the diagnosis and treatment of ovarian adenocarcinomas.
J Reprod Med, 1979/3;22(3):119-27.
PMID: 108399
Impact factor: 0.218
MeSH terms
Adenocarcinoma; Antigens, Neoplasm; Antineoplastic Agents; Biopsy; Castration; Cystadenocarcinoma; Female; Humans; Neoplasm Metastasis; Neoplasm Staging; Ovarian Neoplasms; Ovary; Prognosis; Radiotherapy, High-Energy
More resources
EndNote: Download